KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in IntangiblesChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Change in Inventory: 2017-2024

Historic Change in Inventory for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to $79.6 million.

  • BioNTech SE's Change in Inventory fell 85.33% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year decrease of 27.45%. This contributed to the annual value of $79.6 million for FY2024, which is 9.66% down from last year.
  • Latest data reveals that BioNTech SE reported Change in Inventory of $79.6 million as of FY2024, which was down 9.66% from $88.1 million recorded in FY2023.
  • BioNTech SE's Change in Inventory's 5-year high stood at $88.1 million during FY2023, with a 5-year trough of -$501.5 million in FY2021.
  • For the 3-year period, BioNTech SE's Change in Inventory averaged around $77.3 million, with its median value being $79.6 million (2024).
  • In the last 5 years, BioNTech SE's Change in Inventory slumped by 824.87% in 2020 and then skyrocketed by 112.80% in 2022.
  • BioNTech SE's Change in Inventory (Yearly) stood at -$59.4 million in 2020, then plummeted by 744.65% to -$501.5 million in 2021, then soared by 112.80% to $64.2 million in 2022, then soared by 37.31% to $88.1 million in 2023, then dropped by 9.66% to $79.6 million in 2024.